68-6

76/104

) 土肥静之：ステントグラフト内挿術マニュアル腹部編，日本医事新報社・2020年) 若松禎人，中西啓介，松下　訓，佐藤　剛，康本豪哲，川崎志保理，天野　篤：尿中NGAL640405-411. doi: 10.14740/cr1165. Epub 2020 Nov 2.PMID: 33224387 Free PMC article. 28) Mukaida H, Hayashida M, Matsushita S, Endo D, Oishi A, Shimada A, Hata H, Kajimoto K, Yamamoto T, Amano A: Free triiodothy-ronine (fT3) and B-type natriuretic peptide (BNP) predict in-hospital mortality after valve surgery. Gen Thorac Cardiovasc Surg, 2020; 68: 585-595. 29) Al Shahi H, Kadoguchi T, Shimada K, Fukao K, Matsushita S, Aikawa T, Ouchi S, Shiozawa T, Tkahashi S, Sato-Okabayashi Y, Akita K, Isoda K, Miyazaki T, Daida H: Voluntary exercise and cardiac remodeling in a myocar-dial infarction model. Open Medicine, 2020; 15: 545-55. 30) Matsushita S, Kishida A, Wakamatsu Y, Mukaida H, Yokokawa H, Yamamoto T, Amano A: Factors influencing activated clotting time following heparin administration for the initi-ation of cardiopulmonary bypass. Gen Thorac Cardiovasc Surg, 2020. 31) Miyosawa K, Iwata H, Minami-Takano A, Hayashi H, Tabuchi H, Sekita G, Kadoguchi T, Ishii K, Nozaki Y, Funamizu T, Chikata Y, Matsushita S, Amano A, Sumiyoshi M, Naka-zato Y, Daida H, Minamino T: Enhanced mono-cyte migratory activity in the pathogenesis of structural remodeling in atrial fibrillation. PLoS One, 2020; 15: e0240540. 32) Yazaki K, Takahashi K, Kobayashi M, Yamada M, Iso T, Akimoto S, Shigemitsu S, Matsui K, Akimoto K, Kishiro M, Nakanishi K, Kawasaki S, Shimizu T: Exercise echocar-diography demonstrates potential myocardial damage in patients with repaired tetralogy of Fallot using layer-specific strain analysis. Cardiol Young, 2020; 30: 710-716. 33) Wakamatsu Y, Nakanishi K, Matsushita S, Sato G, Yasumoto H, Kawasaki S, Amano A: Neutrophil gelatinase－associated lipocalin as an early indicator of acute kidney injury following pediatric cardiac surgery. Jpn J Extra-Corporeal Technology, 2020; 47: 8-14. 34) Rohani A, Lam E, Tanjuakio J, Hirose H, Kraft WK, Kaushal G: imultaneous quantita-tive lc-ms method of ketamine, midazolam and their metabolites (dehydronorketamine, norketamine and 1hydroxymidazolam) for its application in patients on extracorporeal membrane oxygenation (ECMO) therapy. J Pharm Biomed Anal, 2020; 178: 112947. 35) Gupta E, Carey K, McDermott L, Cavarocchi N, Hirose H, Baram M: Role of serum cytokine levels in acute respiratory distress syndrome patients on extracorporeal membrane oxygen-ation support. World J Cardiovasc Surg, 2020; 10: 1-10. 36) Sultan I, Habertheuer A, Usman AA, Kilic A, Gnall E, Friscia ME, Zubkus D, Hirose H, Sanchez P, Okusanya O, Szeto WY, Gutsche J: The role of extracorporeal life support for patients with COVID-19: Preliminary results from a statewide experience. J Card Surg, 2020; 35: 1410-1413. 37) Mihama T, Liem S, Cavarocchi N, Hirose H: Outcomes of out-of-hospital extracorporeal membrane oxygenation transfers: significance of initiation site and personnel. Perfusion, 2020 [Epub ahead of print], PMID 31948383. DOI:10.1177/0267659119897784. 38) lazoski C, Yang Q, Hirose H: Outcomes of extracorporeal membrane oxygenation in blood culture positive septic patients. World J Cardiovasc Surg, 2020; 10: 158-166. 39) Ohira S, Kawamura M, Ahern K, Cavarocchi N, Hirose H: Aggressive placement of distal limb perfusion catheter in venoarterial extra-corporeal membrane oxygenation. Intl J Artif Organ, 2020 [Epub ahead of print]. PUBMED ID: 32308098, DOI: 10.1177/0391398820917160. 40) Gupta E, Awsare B, Hirose H, Cavarocchi N, Baram M: Don’t drive blind: driving pressure to optimize ventilator management in ECMO. Lung, 2020 [Epub ahead of print]. PMID: 32705400, DOI 10.1007/s00408-020-00381-y 41) Azuma N, Uchida T, Kikuchi S, Sadahiro M, Shintani T, Yanagi K, Higashita R, Yamashita A, Makita Y, Kaname T: NT5E Genetic Muta-tion Is a Rare but Important Cause of Inter-mittent Claudication and Chronic Limb- Threatenig Ischemia. Circulation Journal, 2020; 84: 1183-1188.〈Reviews〉 1 2